Lonza to Manufacture Selecta Gene Therapy Candidate for MMA – Genetic Engineering & Biotechnology News
|
Lonza to Manufacture Selecta Gene Therapy Candidate for MMA
Genetic Engineering & Biotechnology News Lonza's viral-based therapeutics unit Lonza Houston has agreed to manufacture an Anc80-AAV–based gene therapy product for Selecta Bioscience's proprietary program for the treatment of methylmalonic acidemia (MMA) and may produce other … Lonza and Selecta Biosciences (SELB) Announce Manufacturing Agreement for Anc80-AAV-Based Gene Therapy |
